All stock lists
Actinium Pharmaceuticals, Inc. (ATNM)
NYSE: ATNM · Real-Time Price · USD
Healthcare · Biotechnology
1.40-0.13 (-8.22%)
Insider Score
––Not scored
ATNM Insider Score
Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ATNM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 35.00 M | 0.00 | 0.00 | 90.00 K | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 220.00 K | -615.00 K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 35.00 M | -220.00 K | 615.00 K | 90.00 K | 0.00 | 0.00 |
| SG&A Expense | 2.06 M | 1.70 M | 2.12 M | 1.53 M | 2.62 M | 8.94 M |
| R&D Expense | 5.38 M | 4.20 M | 4.91 M | 4.25 M | 4.88 M | 7.70 M |
| Operating Expenses | 7.43 M | 5.68 M | 7.03 M | 5.78 M | 7.50 M | 16.64 M |
| Operating Income | 27.57 M | -5.90 M | -6.41 M | -5.69 M | -7.50 M | -16.64 M |
| Pretax Income | 27.90 M | -5.52 M | -5.94 M | -5.13 M | -6.88 M | -15.94 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 27.90 M | -5.52 M | -5.94 M | -5.13 M | -6.88 M | -15.94 M |
| EPS (Basic) | 0.89 | -0.18 | -0.19 | -0.16 | -0.22 | -0.51 |
| EPS (Diluted) | 0.89 | -0.18 | -0.19 | -0.16 | -0.22 | -0.51 |
| Shares Outstanding | 31.40 M | 31.24 M | 31.20 M | 31.20 M | 31.20 M | 31.20 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.